SCHEMBL252862

SCHEMBL252862

N#Cc1ccccc1N1CCCCCN1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
ALDH1A1 P00352 3/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD4 P21917 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MMP1 P03956 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
DRD2 P14416 1/20 0.35
GRM5 P41594 1/20 0.35
HTR1A P08908 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4106691 0.82 AR (0.61) AR
SCHEMBL4091463 0.80 AR (0.63) AR
SCHEMBL2490932 0.79 CDC42BPB (0.42)
SCHEMBL31388194 0.77 AR (0.62) ARALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL7528396 0.77 AR (0.62) ARALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL7524105 0.77 AR (0.62) ARALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL1660394 0.77 AR (0.62) ARALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL2490935 0.76 KDM4E (0.43) ALDH1A1MAPTDRD4KDM4EDRD2
SCHEMBL4105747 0.75 AR (0.60) AR
SCHEMBL829177 0.75 AR (0.65) ARALDH1A1POLBMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003418-A2 FUNCTIONALLY SELECTIVE LIGANDS OF DOPAMINE D2 RECEPTORS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-01-05 WO claimed
WO-2003101994-A1 FUSED BICYCLIC AROMATIC COMPOUNDS THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-11 WO claimed
EP-2872514-A1 IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2015-05-20 EP disclosed
WO-2014011974-A1 IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-01-16 WO disclosed
WO-2003101994-A1 FUSED BICYCLIC AROMATIC COMPOUNDS THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-11 WO disclosed